FDA Alerts
FDA Approves New Psoriasis Rx
The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.
FDA Approves Orbactiv to Treat Skin Infections
The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
FDA Approves Botox Cosmetic to Improve the Appearance of Crows Feet Lines
The US Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines, known as crow’s feet, in adults.
FDA Warns of Rare but Serious Skin Reactions With the Pain Reliever/Fever Reducer Acetaminophen
The US Food and Drug Administration (FDA) is informing the public that acetaminophen has been associated with a risk of rare but serious skin reactions.
Wicked Itch
The FDA has just approved the topical ointment Natroba for the treatment of head lice in adults and children over the age of four.